#68Official Top 100
Luye Pharma
烟台绿叶医药控股(集团)有限公司
#68
Chemical medicines and finished dosage formsSterile productsOncology, ADC and high-potency
Manufacturing profile
Chemical medicines and finished dosage forms
Sterile products
Oncology, ADC and high-potency
Selection basis
The company is included in the official 2024 ranking of the 100 largest Chinese pharmaceutical-industry enterprises by main-business revenue.
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Representative manufacturing and QC chain
- 1Raw-material receipt and identification
- 2Dispensing, blending and granulation
- 3Tableting, encapsulation or solution preparation
- 4Packaging and labelling
- 5HPLC, GC, KF, ICP/AAS, dissolution and stability QC
- 6WFI, clean steam and cleanroom HVAC
- 7Solution preparation and bioburden control
- 8Sterile filtration
- 9Isolator/RABS filling or lyophilisation
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerContent Uniformity Quality CheckerDissolution Apparatus 1 & 2 Quality CheckerStability Condition Monitoring Quality CheckerSterility Test Membrane Filtration Quality CheckerBacterial Endotoxins LAL Quality CheckerParticle Count Injection USP <788> Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand the scope.
Mapping boundary
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Methodology